Patient Quality of Recovery After TAVR With Different Sedation Regimens
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 126 participants.
Also called NCT07556523
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 126 participants
- Sponsor
- David Lyubashevsky
- Registry
-
NCT07556523
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT07556523. Randomized; double masking; primary purpose treatment. Start 2026-03-16 (actual); primary completion 2028-04 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Patient Quality of Recovery After TAVR With Different Sedation Regimens
- Condition
- Aortic Valve Stenosis
- Intervention (Drug)
- Propofol
- Intervention (Drug)
- Dexmedetomidine
- Intervention (Drug)
- Midazolam
- Intervention (Drug)
- Fentanyl
- Lead sponsor
- David Lyubashevsky
Record details
- Record id
cardio:ct-nct07556523- Content hash
758412bca30975f8d8c4c8a96d3b85152dbf978f20d6b72681cf8ddf97c6fb5d